Literature DB >> 19959674

Measures for assessing subjective effects of potential reduced-exposure products.

Karen Hanson1, Richard O'Connor, Dorothy Hatsukami.   

Abstract

Potential reduced-exposure products (PREP) may reduce toxicant exposure and thereby may possibly reduce health risks associated with conventional tobacco use. However, lessened health risk to the individual or harm to the population through the use of PREPs is unknown. Research is being conducted to evaluate the possible health effects associated with PREP use. As part of this evaluation, it is critical to provide sound measures of subjective responses to PREPs to determine the use and the abuse potential of a product, that is, the likelihood that the product will lead to addiction. The goal of this paper is to conduct a systematic review of scales that have been used to measure the subjective responses to PREPs and examine their characteristics. In this article, scales are identified and the items on the scales are described. Scales are also examined to determine whether they are sensitive in testing PREPs. Furthermore, scales to assess PREPs are recommended to investigators. Where no scales exist, items that may be critical for the development and validation of new scales are identified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959674      PMCID: PMC2821025          DOI: 10.1158/1055-9965.EPI-09-0971

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  61 in total

1.  Nicotine discrimination and self-administration in humans as a function of smoking status.

Authors:  K A Perkins; M Sanders; D D'Amico; A Wilson
Journal:  Psychopharmacology (Berl)       Date:  1997-06       Impact factor: 4.530

2.  Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.

Authors:  S G Gourlay; A Forbes; T Marriner; D Pethica; J J McNeil
Journal:  BMJ       Date:  1995-08-05

3.  Assessing the sensory role of nicotine in cigarette smoking.

Authors:  W S Pritchard; J H Robinson; T D Guy; R A Davis; M F Stiles
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Dissociating the nicotine and airway sensory effects of smoking.

Authors:  E C Westman; F M Behm; J E Rose
Journal:  Pharmacol Biochem Behav       Date:  1996-02       Impact factor: 3.533

5.  Desire to smoke during spaced smoking intervals.

Authors:  K J Schuh; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

6.  Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers.

Authors:  M F Butschky; D Bailey; J E Henningfield; W B Pickworth
Journal:  Pharmacol Biochem Behav       Date:  1995-01       Impact factor: 3.533

7.  Transdermal nicotine for active ulcerative colitis.

Authors:  R D Pullan; J Rhodes; S Ganesh; V Mani; J S Morris; G T Williams; R G Newcombe; M A Russell; C Feyerabend; G A Thomas
Journal:  N Engl J Med       Date:  1994-03-24       Impact factor: 91.245

8.  Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal.

Authors:  J Gross; J Lee; M L Stitzer
Journal:  Pharmacol Biochem Behav       Date:  1997 May-Jun       Impact factor: 3.533

9.  Nicotine or tar titration in cigarette smoking behavior?

Authors:  M Hasenfratz; B Baldinger; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.

Authors:  E D Levin; E C Westman; R M Stein; E Carnahan; M Sanchez; S Herman; F M Behm; J E Rose
Journal:  J Clin Psychopharmacol       Date:  1994-02       Impact factor: 3.153

View more
  13 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

Review 2.  Postmarketing surveillance for "modified-risk" tobacco products.

Authors:  Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2011-01-20       Impact factor: 4.244

3.  Subjective responses to oral tobacco products: scale validation.

Authors:  Dorothy K Hatsukami; Yan Zhang; Richard J O'Connor; Herb H Severson
Journal:  Nicotine Tob Res       Date:  2012-12-13       Impact factor: 4.244

4.  Water pipe steam stones: familiarity and use among US young adults.

Authors:  Jaime E Sidani; Ariel Shensa; Brian A Primack
Journal:  Nicotine Tob Res       Date:  2014-08-21       Impact factor: 4.244

Review 5.  Tobacco and nicotine product testing.

Authors:  Dorothy K Hatsukami; Lois Biener; Scott J Leischow; Mitch R Zeller
Journal:  Nicotine Tob Res       Date:  2011-04-02       Impact factor: 4.244

6.  Construct validity of the Cigarette Ratings Scale and associations with tobacco use and product feature outcomes.

Authors:  Andrea C Johnson; Melissa Mercincavage; Valentina Souprountchouk; Anupreet K Sidhu; Andrea C Villanti; Cristine D Delnevo; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2022-03-08       Impact factor: 4.852

7.  Effect on Tobacco Use and Subjective Measures of Including E-cigarettes in a Simulated Ban of Menthol in Combustible Cigarettes.

Authors:  Michael Kotlyar; Ryan Shanley; Sheena R Dufresne; Gretchen A Corcoran; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

8.  Providing a Science Base for the Evaluation of Tobacco Products.

Authors:  Micah L Berman; Greg Connolly; K Michael Cummings; Mirjana V Djordjevic; Dorothy K Hatsukami; Jack E Henningfield; Matthew Myers; Richard J O'Connor; Mark Parascandola; Vaughan Rees; Jerry M Rice; Peter G Shields
Journal:  Tob Regul Sci       Date:  2015-04

9.  Perceptions of Snus Among US Adult Smokers Given Free Product.

Authors:  Ellen Meier; Jessica L Burris; Amy Wahlquist; Elizabeth Garrett-Mayer; Kevin M Gray; Anthony J Alberg; K Michael Cummings; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2017-12-13       Impact factor: 4.244

10.  Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes.

Authors:  Patrick Picavet; Christelle Haziza; Nicola Lama; Rolf Weitkunat; Frank Lüdicke
Journal:  Nicotine Tob Res       Date:  2015-10-05       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.